QQ客服 官方微博 反馈留言

	Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial
	Zhao, C.; Miao, J.; Shen, G.; Li, J.; Shi, M.; Zhang, N.; Hu, G.; Chen, X.; Hu, X.; Wu, S.
刊名	ANNALS OF ONCOLOGY
	2019
卷号	30期号:4
关键词	nasopharyngeal carcinoma distant metastasis anti-epidermal growth factor receptor monoclonal antibody chemotherapy efficacy adverse effects
ISSN号	0923-7534
DOI	10.1093/annonc/mdz020
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4263010
专题	武汉大学
推荐引用方式 GB/T 7714	Zhao, C.,Miao, J.,Shen, G.,et al. Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial[J]. ANNALS OF ONCOLOGY,2019,30(4).
APA	Zhao, C..,Miao, J..,Shen, G..,Li, J..,Shi, M..,...&Xie, C..(2019).Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial.ANNALS OF ONCOLOGY,30(4).
MLA	Zhao, C.,et al."Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial".ANNALS OF ONCOLOGY 30.4(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。